查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1461335

CRISPR 技术市场：按产品、按应用、按最终用户、按地区 - 市场规模、份额、展望、机会分析，2024-2031 年

CRISPR Technology Market, By Product, By Application, By End User, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031
出版日期: | 出版商: Coherent Market Insights | 英文 169 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2024 年，全球 CRISPR 技术市场将达到 36.421 亿美元，预计在预测期内（2024-2031 年）复合年增长率为 19.2%。

报告范围 报告详情
基准年 2023年 2023/2024年市场规模 36.421 亿美元
实际资料 2019-2023 预测期 2024-2031
预测期2023/2024-2030/2031复合年增长率 19.20% 2030/2031 年预测值 124.61亿美元
2024 年按地区分類的 CRISPR 技术全球市场规模（百万美元）
CRISPR技术市场-IMG1

CRISPR 技术正在推动医学、製药、生物技术和农业领域基因组编辑的进步，使世界各地的科学家能够透过更快、更有效率的基因组编辑来研究这些领域。 CRISPR 也被用于纠正遗传缺陷、治疗人类疾病和收穫更好的作物品种。 CRISPR 有许多潜在的应用，包括治疗和预防疾病传播、纠正遗传缺陷和改良作物。 CRISPR-Cas9系统有广泛的应用。在医学领域，它应用于癌症、病毒感染、遗传疾病和病原体检测的研究。 CRISPR是一种有潜力改变世界的基因编辑技术。

市场动态：

COVID-19在全球范围内的爆发、正在进行的临床试验数量的增加以及基因编辑工具的不断探索是预计在预测期内促进全球CRISPR技术市场增长的关键因素。例如，2020 年 3 月，多伦多大学的科学家开发了 CHyMErA，这是一种基于 CRISPR 的工具，用于更通用的基因组编辑。

CRISPR技术在COVID-19的预防和控制方面具有巨大的应用潜力。 2020 年 3 月，纽约基因组中心的研究人员开发了一种新的 CRISPR筛检技术，该技术针对 RNA，包括新型病毒 (COVID-19) 的 RNA。此外，2019 年 11 月，瑞士苏黎世联邦理工学院的研究人员以 CAS12a 取代了 CAS9 酶，使他们能够编辑 25 个目标位点的基因。

本研究的主要特点

  • 本报告对全球CRISPR技术市场进行了详细分析，并提出了以2023年为基准年的预测期（2024-2031）的市场规模和年复合成长率（CAGR%）。
  • 它还阐明了各个细分市场的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
  • 它根据以下参数（例如公司亮点、产品系列、主要亮点、财务表现和策略）介绍了全球 CRISPR 技术市场的主要企业。
  • 该报告的见解预计将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球 CRISPR 技术市场报告迎合了该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员可以透过分析全球 CRISPR 技术市场时所使用的各种策略矩阵来促进决策。

目录：

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • 一致的机会地图 (COM)

第三章市场动态、法规及趋势分析

  • 市场动态
    • CRISPR 的需求和采用增加
    • CRISPR高成本
    • COVID-19 爆发（全球大流行）
  • 影响分析
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景

第四章全球 CRISPR 技术市场 - 冠状病毒 (COVID-19) 大流行的影响

  • COVID-19 流行病学
  • 供需面分析
  • 经济影响

第 5 章 全球 CRISPR 技术市场（按产品），2019-2031 年

  • 介绍
  • 酵素
  • 套件和试剂
  • 引导RNA
  • 其他的

第六章 2019-2031 年全球 CRISPR 技术市场（按应用）

  • 介绍
    • 2024年及2031年市场占有率分析（%）
    • 与前一年同期比较成长分析
    • 细分市场趋势
  • 生物医学
    • 介绍
    • 市场规模及预测、与前一年同期比较成长率
  • 农业
    • 介绍
    • 市场规模及预测、与前一年同期比较成长率
  • 产业
    • 介绍
    • 市场规模及预测、与前一年同期比较成长率
  • 其他的
    • 介绍
    • 市场规模及预测、与前一年同期比较成长率

第 7 章 2019-2031 年全球 CRISPR 技术市场（按最终用户）

  • 介绍
  • 製药和生物技术公司
  • 学术和政府研究机构
  • 其他（CRO等）

第8章2019-2031年全球CRISPR技术市场（按地区）

  • 介绍
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲
  • 其他的

第9章 竞争格局

  • Merck KGaA
  • Thermo Fisher Scientific
  • Origene Technologies, Inc.
  • New England Biolabs
  • GenScript
  • GeneCopoeia, Inc.
  • Cellecta, Inc.
  • Agilent Technologies, Inc.
  • PerkinElmer, Inc.（Horizon Discovery Ltd.）
  • Danaher Corporation（Integrated DNA Technologies）

第10章分析师建议

  • 繁荣与衰落
  • 综合机会图

第11章 章节

  • 参考
  • 调查方法
简介目录
Product Code: CMI5175

The global CRISPR technology market is estimated to be valued at US$ 3,642.1 Mn in 2024 and is expected to exhibit a CAGR of 19.2% during the forecast period (2024-2031).

Report Coverage Report Details
Base Year: 2023 Market Size in 2023/2024: US$ 3,642.1 Mn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR: 19.20% 2030/2031 Value Projection: US$ 12,461 Mn
Global CRISPR Technology Market Value (USD MN), by Region, 2024
CRISPR Technology Market - IMG1

CRISPR technology is driving advances in genome editing across medicine, pharmaceutical, biotechnology, and agriculture, which has enabled scientists to conduct research in these fields through faster and more efficient genome editing across the world. CRISPR is also used to correct genetic defects, treat human diseases, and yield better crop varieties. It has a number of potential applications that include treating and preventing the spread of diseases, correcting genetic defects, and also, improving crops. The CRISPR-Cas9 system has a wide diversity of applications. In medicine, it has been applied in research related to cancer, virus infections, genetic diseases and detection of pathogens. CRISPR is a technology that can be used to edit genes and, as such, will likely change the world.

Market Dynamics:

The outbreak of COVID-19 across the globe, increasing number of ongoing clinical trials, and expanding research in gene editing tools are some major factors expected to augment growth of the global CRISPR Technology market during the forecast period. For instance, in March 2020, scientists at the University of Toronto developed CHyMErA, a CRISPR-based tool for more versatile genome editing.

CRISPR technology have great potential for application in both the prevention and control of COVID-19. In March 2020, researchers at New York genome center developed a new CRISPR screening technology to target RNA, including RNA of novel viruses (COVID-19). Moreover, in November 2019, researchers at ETH Zurich, Switzerland, swapped CAS9 enzyme for CAS 12a, which allowed the researchers to edit genes in 25 target sites.

Key features of the study:

  • This report provides in-depth analysis of the global CRISPR Technology market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global CRISPR Technology market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Merck KGaA, Thermo Fisher Scientific, Origene Technologies, Inc., New England Biolabs, GenScript, GeneCopoeia, Inc., Cellecta, Inc., Agilent Technologies, Inc., PerkinElmer, Inc. (Horizon Discovery Ltd.), and Danaher Corporation (Integrated DNA Technologies), among others
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global CRISPR Technology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global CRISPR Technology market.

Detailed Segmentation:

  • Global CRISPR Technology Market, By Product:
    • Enzymes
    • Kits & Reagents
    • Guide RNA
    • Others
  • Global CRISPR Technology Market, By Application:
    • Biomedical
    • Agricultural
    • Industrial
    • Others
  • Global CRISPR Technology Market, By End User:
    • Pharmaceutical companies and Biotechnology Companies
    • Academics and Government Research Institutes
    • Others (CROs etc.)
  • Global CRISPR Technology Market, By Geography:
    • North America
    • Europe
    • Asia-Pacific
    • Middle East and Africa
    • South America
  • Key Players Insights
    • Merck KGaA
    • Thermo Fisher Scientific
    • Origene Technologies, Inc.
    • New England Biolabs
    • GenScript
    • GeneCopoeia, Inc.
    • Cellecta, Inc.
    • Agilent Technologies, Inc.
    • PerkinElmer, Inc. (Horizon Discovery Ltd.)
    • Danaher Corporation (Integrated DNA Technologies)

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rising demand and adoption of CRISPR
    • High cost of CRISPR
    • The outbreak of COVID-19 (global pandemic)
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global CRISPR Technology Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global CRISPR Technology Market, By Product, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Enzymes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Kits & Reagents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Guide RNA
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

6. Global CRISPR Technology Market, Application, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Biomedical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Agricultural
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Industrial
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

7. Global CRISPR Technology Market, By End User, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Pharmaceutical companies and Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Academics and Government Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Others (CROs etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

8. Global CRISPR Technology Market, By Region, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
  • Rest of World
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)

9. Competitive Landscape

  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Origene Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • New England Biolabs
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GenScript
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GeneCopoeia, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cellecta, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Agilent Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • PerkinElmer, Inc. (Horizon Discovery Ltd.)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Danaher Corporation (Integrated DNA Technologies)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

10. Analyst Recommendation

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. Section

  • References
  • Research Methodology
  • About Us and Sales Contact